Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 5 | 6 |
| List of Tables | 8 | 1 |
| List of Figures | 9 | 2 |
| Introduction | 11 | 1 |
| GBI Research Guidance | 11 | 1 |
| Global In Vitro Diagnostics Market: Market Characterization | 12 | 14 |
| Global in Vitro Diagnostics Market, Revenue ($bn), 2004 2011 | 12 | 2 |
| Global In Vitro Diagnostics Market, Revenue ($bn), 2011 2018 | 14 | 2 |
| Global In Vitro Diagnostics Market, Key Company Shares (%), 2010 | 16 | 1 |
| Global In Vitro Diagnostics Market: Key Market Trends | 17 | 1 |
| Growing Trend towards Preventive Healthcare is Driving the Growth of In Vitro Diagnostics | 17 | 1 |
| Increased Use of Information Technology in IVD for Effective Workflow Management | 18 | 1 |
| Laboratory Consolidation is a Major Trend in the IVD Industry | 19 | 2 |
| Demand for Decentralized Laboratory Testing is increasing Significantly Across the World | 21 | 1 |
| Consolidation Activity has Increased Significantly in the IVD Industry in Recent Years | 21 | 1 |
| Automation is the Key Technology Trend in IVD Market | 22 | 2 |
| Global In Vitro Diagnostics Market: Market Dynamics | 24 | 1 |
| Market Drivers | 24 | 1 |
| Growing Demand for IVD in Developing Countries to Drive the IVD Market | 24 | 1 |
| Increasing Global Elderly Population will Drive the Growth of the IVD Market | 24 | 1 |
| Market Restraints | 25 | 1 |
| Negative Pricing Pressure to Impact IVD Market Growth | 25 | 1 |
| Lack of Adequate Reimbursements to Negatively Impact the Growth of the IVD Market | 25 | 1 |
| Slow Rate of Return on Investment Stagnates the Adoption Rate of Innovative Technology | 25 | 1 |
| Global In Vitro Diagnostics Market: Market Category Analysis and Forecasts | 26 | 38 |
| In Vitro Diagnostics Market: Cross-Category Analysis | 26 | 2 |
| Immunochemistry | 28 | 1 |
| Immunochemistry Market, Global, Revenue ($m), 2004 2011 | 28 | 1 |
| Immunochemistry Market, Global, Revenue ($m), 2011 2018 | 29 | 1 |
| Immunochemistry Market, Global, Company Share, (%), 2010 | 30 | 2 |
| Immunochemistry Market: Market Dynamics | 32 | 1 |
| Market Drivers | 32 | 1 |
| Broad Menu of Tests Covered Under Immunochemistry to Drive the Market Growth | 32 | 1 |
| Significant Increase in Reagent Consumption is Driving the Immunochemistry Market. | 32 | 1 |
| Introduction of Advanced Technology Such as Electrochemiluminescence to Drive the Market Growth | 33 | 1 |
| Market Restraints | 34 | 1 |
| Lack of Standardization of Immunochemistry Tests Hinders the Growth of the Immunochemistry Market | 34 | 1 |
| Clinical Chemistry | 35 | 1 |
| Clinical Chemistry Market, Global, Revenue ($m), 2004 2011 | 35 | 1 |
| Clinical Chemistry Market, Global, Revenue ($m), 2011 2018 | 36 | 1 |
| Clinical Chemistry Market, Global, Key Company Shares, (%), 2010 | 37 | 2 |
| Clinical Chemistry Market: Market Dynamics | 39 | 1 |
| Market Drivers | 39 | 1 |
| Technological Advances in Clinical Chemistry Analyzers to Drive the Growth of the Clinical Chemistry Market | 39 | 1 |
| Improved Accessibility and Affordability of Clinical Chemistry Rapid Tests and POC in Emerging Countries to Drive the Clinical Chemistry Market | 40 | 1 |
| Non-Medical Testing and Clinical Trials to Drive the Demand in the Clinical Chemistry Market | 41 | 1 |
| Market Restraints | 41 | 1 |
| Lab Consolidation Leading to Reduced Profit Margins Acts as a Major Deterrent for the Clinical Chemistry Market | 41 | 1 |
| Market Maturation and Low Replacement Rates of Automated Clinical Chemistry Analyzers in Developed Countries to Hinder Market Growth | 41 | 1 |
| Infectious Immunology | 42 | 1 |
| Infectious Immunology Market, Global, Revenue ($m), 2004 2011 | 42 | 1 |
| Infectious Immunology Market, Global, Revenue ($m), 2011 2018 | 43 | 1 |
| Infectious Immunology Market, Global, Key Company Shares, (%), 2010 | 44 | 1 |
| Infectious Immunology Market: Market Dynamics | 45 | 1 |
| Market Drivers | 45 | 1 |
| Increasing Burden of Infectious Diseases to Drive the Growth of the Infectious Immunology Market | 45 | 1 |
| Availability of Rapid Tests to Drive the Market Growth | 45 | 1 |
| Market Restraints | 46 | 1 |
| Lack of Adequate Reimbursement for Innovative Technologies will Deter Market Growth | 46 | 2 |
| Hematology Market, Global, Revenue ($m), 2011 2018 | 48 | 1 |
| Hematology Market, Global, Key Company Shares, (%), 2010 | 49 | 1 |
| Hematology Market: Market Dynamics | 50 | 1 |
| Market Drivers | 50 | 1 |
| Technological Advances are expected to drive the Hematology Market Growth | 50 | 1 |
| Market Restraints | 50 | 1 |
| Shortage of Skilled Laboratory Technicians to Deter Market Growth | 50 | 1 |
| Microbiology Culture | 51 | 1 |
| Microbiology Culture Market, Global, Revenue ($m), 2004 2011 | 51 | 1 |
| Microbiology Culture Market, Global, Revenue ($m), 2011 2018 | 52 | 1 |
| Microbiology Culture Market, Global, Company Shares, (%), 2010 | 53 | 1 |
| Microbiology Culture Market: Market Dynamics | 54 | 1 |
| Market Drivers | 54 | 1 |
| Cost Effectiveness of Microbiology Culture Tests to Increase the Adoption Rates in Developing Countries | 54 | 1 |
| Market Restraints | 54 | 1 |
| Slow Turnaround Time to Negatively Impact the Growth of the Market | 54 | 1 |
| Histology and Cytology | 55 | 1 |
| Histology and Cytology Market, Global, Revenue ($m), 2004 2011 | 55 | 1 |
| Histology and Cytology Market, Global, Revenue ($m), 2011 2018 | 56 | 1 |
| Histology and Cytology Market, Global, Company Share, (%), 2010 | 57 | 1 |
| Histology and Cytology Market: Market Dynamics | 58 | 1 |
| Market Drivers | 58 | 1 |
| Increasing incidence of Cancer to Drive the Histology and Cytology Market Growth | 58 | 1 |
| Market Restraints | 58 | 1 |
| Advanced Molecular Tests to Negatively Impact the Growth of the Infectious Immunology Market | 58 | 1 |
| Genetic Testing | 59 | 1 |
| Genetic Testing Market, Global, Revenue ($m), 2004 2011 | 59 | 1 |
| Genetic Testing Market, Global, Revenue ($m), 2011 2018 | 60 | 1 |
| Genetic Testing Market, Global, Company Share, (%), 2010 | 61 | 1 |
| Genetic Testing Market: Market Dynamics | 62 | 1 |
| Market Drivers | 62 | 1 |
| Direct to-Consumer Genetic Testing to Drive the Market Growth | 62 | 1 |
| Personalized Medicine to Drive the Genetic Testing Market | 62 | 1 |
| Increasing Application of Genetic Testing for the Diagnosis of Infectious Diseases is Driving the Market Growth | 63 | 1 |
| Market Restraints | 63 | 1 |
| High Price of Genetic Testing to Negatively Impact the Market Growth | 63 | 1 |
| Unsatisfactory Standardization of Genetic Testing to Slow Down the Market Growth | 63 | 1 |
| Global In Vitro Diagnostics Market: Country Analysis and Forecasts | 64 | 26 |
| In Vitro Diagnostics Market: Cross-Country Analysis | 64 | 2 |
| Historic and Forecast Revenue, By Country | 66 | 1 |
| In Vitro Diagnostics Market, The US, Revenue ($m), 2004 2011 | 66 | 1 |
| In Vitro Diagnostics Market, the US, Revenue ($m), 2011 2018 | 67 | 1 |
| In Vitro Diagnostics Market, Canada, Revenue ($m), 2004 2011. | 68 | 1 |
| In Vitro Diagnostics Market, Canada, Revenue ($m), 2011 2018 | 69 | 1 |
| In Vitro Diagnostics Market, the UK, Revenue ($m), 2004 2011 | 70 | 1 |
| In Vitro Diagnostics Market, the UK, Revenue ($m), 2011 2018 | 71 | 1 |
| In Vitro Diagnostics Market, Germany, Revenue ($m), 2004 2011 | 72 | 1 |
| In Vitro Diagnostics Market, Germany, Revenue ($m), 2011 2018 | 73 | 1 |
| In Vitro Diagnostics Market, France, Revenue ($m), 2004 2011 | 74 | 1 |
| In Vitro Diagnostics Market, France, Revenue ($m), 2011 2018 | 75 | 1 |
| In Vitro Diagnostics Market, Italy, Revenue ($m), 2004 2011 | 76 | 1 |
| In Vitro Diagnostics Market, Italy, Revenue ($m), 2011 2018 | 77 | 1 |
| In Vitro Diagnostics Market, Spain, Revenue ($m), 2004 2011 | 78 | 1 |
| In Vitro Diagnostics Market, Spain, Revenue ($m), 2011 2018 | 79 | 1 |
| In Vitro Diagnostics Market, Japan, Revenue ($m), 2004 2011 | 80 | 1 |
| In Vitro Diagnostics Market, Japan, Revenue ($m), 2011 2018 | 81 | 1 |
| In Vitro Diagnostics Market, China, Revenue ($m), 2004 2011 | 82 | 1 |
| In Vitro Diagnostics Market, China, Revenue ($m), 2011 2018 | 83 | 1 |
| In Vitro Diagnostics Market, India, Revenue ($m), 2004 2011 | 84 | 1 |
| In Vitro Diagnostics Market, India, Revenue ($m), 2011 2018 | 85 | 1 |
| In Vitro Diagnostics Market, Australia, Revenue ($m), 2004 2011 | 86 | 1 |
| In Vitro Diagnostics Market, Australia, Revenue ($m), 2011 2018 | 87 | 1 |
| In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004 2011 | 88 | 1 |
| In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011 2018 | 89 | 1 |
| Global In Vitro Diagnostics Market: Competitive Assessment | 90 | 10 |
| Key Market Participants | 91 | 1 |
| F. Hoffmann La Roche Ltd. | 91 | 1 |
| Business Overview | 91 | 1 |
| Marketed Products | 91 | 1 |
| Siemens Healthcare (Subsidiary of Siemens AG) | 92 | 1 |
| Business Overview | 92 | 1 |
| Marketed Products | 93 | 1 |
| Abbott Laboratories | 93 | 1 |
| Business Overview | 93 | 1 |
| Marketed Products | 94 | 1 |
| Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) | 94 | 1 |
| Business Overview | 94 | 1 |
| Marketed Products | 94 | 1 |
| Ortho Clinical Diagnostics Inc. (Subsidiary of Johnson &Johnson) | 95 | 1 |
| Business Overview | 95 | 1 |
| Marketed Products | 95 | 1 |
| bioMerieux S.A. (Subsidiary of Merieux Alliance group) | 95 | 1 |
| Business Overview | 96 | 1 |
| Marketed Products | 96 | 1 |
| Sysmex Corporation (Sysmex) | 96 | 1 |
| Business Overview | 96 | 1 |
| Marketed Products | 97 | 1 |
| Becton, Dickinson and Company | 97 | 1 |
| Business Overview | 97 | 1 |
| Marketed Products | 98 | 1 |
| Bio Rad Laboratories, Inc. (Bio Rad) | 98 | 1 |
| Business Overview | 98 | 1 |
| Marketed Products | 98 | 1 |
| Alere Inc. (formerly Inverness Medical Innovations, Inc.) | 99 | 1 |
| Business Overview | 99 | 1 |
| Marketed Products | 99 | 1 |
| Global In Vitro Diagnostics Market: Product Pipeline Analysis | 100 | 12 |
| In Vitro Diagnostics Market: Pipeline Products Summary | 100 | 2 |
| Pipeline Products Analysis: Immunochemistry Market | 102 | 1 |
| Pipeline Products Analysis: Infectious Immunology | 103 | 1 |
| Pipeline Products Analysis: Genetic Testing | 104 | 1 |
| Pipeline Products Analysis: Clinical Chemistry | 105 | 1 |
| Pipeline Products Analysis: Hematology | 106 | 1 |
| Pipeline Products Analysis: Microbiology Culture | 107 | 1 |
| Pipeline Products Analysis: Histology and Cytology | 108 | 1 |
| In Vitro Diagnostics Market: Profiles of Key Pipeline Products | 109 | 1 |
| ImmProCon Technology | 109 | 1 |
| RAPIDPoint 500 System Lactate Assay | 109 | 1 |
| Sali Chek Reader | 109 | 1 |
| Point-of-Care Diagnostic Device | 110 | 1 |
| ACE Alera Clinical Chemistry System Direct A1c Assay | 110 | 1 |
| Advia 120 Hematology System IRF Test | 110 | 1 |
| Advia 2120 Hematology System MPC Test | 111 | 1 |
| AIA 600 II D dimer Test | 111 | 1 |
| Global In Vitro Diagnostics Market: Consolidation Landscape | 112 | 16 |
| Deals by Number, 2008 2011 | 112 | 8 |
| In Vitro Diagnostics Market: Key Deals, 2008 2011 | 120 | 1 |
| Roche Completes Acquisition of mtm laboratories | 120 | 1 |
| Deal Rationale | 120 | 1 |
| bioMerieux Acquires Argene | 120 | 1 |
| Deal Rationale | 120 | 1 |
| Thermo Fisher Completes Acquisition of Phadia | 120 | 1 |
| Deal Rationale | 121 | 1 |
| Quest Diagnostics Completes Acquisition of Athena Diagnostics | 121 | 1 |
| Deal Rationale | 121 | 1 |
| Danaher Completes Acquisition of Beckman Coulter | 121 | 1 |
| Deal Rationale | 121 | 1 |
| Laboratory Corporation of America Completes Acquisition of Genzyme Genetics From Genzyme | 122 | 1 |
| Deal Rationale | 122 | 1 |
| Merck Completes Acquisition of Millipore | 122 | 1 |
| Deal Rationale | 122 | 1 |
| Thermo Fisher Scientific Completes Acquisition of Ahura Scientific | 122 | 1 |
| Deal Rationale | 122 | 1 |
| Inverness Medical Innovations Acquires 78.13% Stake in Standard Diagnostics | 123 | 1 |
| Deal Rationale | 123 | 1 |
| Quidel Completes Acquisition of Diagnostic HYBRIDS | 123 | 1 |
| Deal Rationale | 123 | 1 |
| Danaher Completes Acquisition of Genetix Group | 123 | 1 |
| Deal Rationale | 123 | 1 |
| QIAGEN Completes Acquisition of DxS | 123 | 1 |
| Deal Rationale | 124 | 1 |
| Thermo Fisher Scientific Completes Acquisition of B.R.A.H.M.S. | 124 | 1 |
| Deal Rationale | 124 | 1 |
| Laboratory Corporation of America Holdings Completes Acquisition of Monogram Biosciences | 124 | 1 |
| Deal Rationale | 124 | 1 |
| Inverness Medical Innovations Completes Acquisition of Concateno From Marwyn | 125 | 1 |
| Deal Rationale | 125 | 1 |
| Gen Probe Acquires Tepnel Life Sciences | 125 | 1 |
| Deal Rationale | 125 | 1 |
| Hologic Acquires Third Wave Technologies | 125 | 1 |
| Deal Rationale | 125 | 1 |
| Immucor Acquires BioArray Solutions | 125 | 1 |
| Deal Rationale | 125 | 1 |
| Werfen Life Acquires INOVA Diagnostics | 126 | 1 |
| Deal Rationale | 126 | 1 |
| Abbott Laboratories Acquires Ibis Biosciences from Isis Pharmaceuticals | 126 | 1 |
| bioMerieux Acquires AviaraDx | 126 | 1 |
| Deal Rationale | 126 | 1 |
| Bio Rad Laboratories Acquires Diamed | 127 | 1 |
| Deal Rationale | 127 | 1 |
| Appendix | 128 | 9 |
| Definitions | 128 | 6 |
| Clinical Chemistry | 128 | 1 |
| Enzyme Chemistry Reagents | 128 | 1 |
| Metabolite Chemistry Reagents | 128 | 1 |
| Electrolyte Chemistry Reagents | 128 | 1 |
| Clinical Chemistry Rapid Tests &POC | 128 | 1 |
| Clinical Chemistry Analyzers | 128 | 1 |
| Urine Analysis | 128 | 1 |
| Immunochemistry Test Reagents | 129 | 1 |
| Specific Proteins | 129 | 1 |
| Endocrinology Tests | 129 | 1 |
| Drug Related Testing | 129 | 1 |
| Disease Specific Immunochemistry | 129 | 1 |
| Organ Function Assays | 130 | 1 |
| Immunochemistry Rapid Tests | 130 | 1 |
| Immunochemistry Analyzers | 130 | 1 |
| Hematology | 130 | 1 |
| Hematology Reagents | 130 | 1 |
| Hematology Analyzers | 130 | 1 |
| Hemostasis | 130 | 1 |
| Hematology Cell Counters | 131 | 1 |
| Immuno Hematology | 131 | 1 |
| Hematology Rapid Tests | 131 | 1 |
| Histology And Cytology | 131 | 1 |
| Histology | 131 | 1 |
| Cytology | 132 | 1 |
| Microbiology Culture | 132 | 1 |
| Blood Culture | 132 | 1 |
| Mycobacteria Culture | 132 | 1 |
| Bacterial Identification &Susceptibility Testing | 132 | 1 |
